ERBB2 c.2967C>G ;(p.I989M)

Variant ID: 17-37882909-C-G

NM_004448.2(ERBB2):c.2967C>G;(p.I989M)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response.

Therapeutic Advances In Medical Oncology
Ciriaco, Nikaoly N; Zamora, Esther E; Escrivá-de-Romaní, Santiago S; Miranda Gómez, Ignacio I; Jiménez Flores, José J; Saura, Cristina C; Sloane, Hillary H; Starus, Anna A; Fredebohm, Johannes J; Georgieva, Lucy L; Speight, Graham G; Jones, Frederick F; Ramón Y Cajal, Santiago S; Espinosa-Bravo, Martín M; Peg, Vicente V
Publication Date: 2022

Variant appearance in text: ERBB2: Ile989Met
PubMed Link: 36479470
Variant Present in the following documents:
  • Main text
  • 10.1177_17588359221139601.pdf
View BVdb publication page



Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma.

Frontiers In Oncology
Arildsen, Nicolai Skovbjerg NS; Jönsson, Jenny-Maria JM; Bartuma, Katarina K; Ebbesson, Anna A; Westbom-Fremer, Sofia S; Måsbäck, Anna A; Malander, Susanne S; Nilbert, Mef M; Hedenfalk, Ingrid A IA
Publication Date: 2017

Variant appearance in text: ERBB2: Ile989Met
PubMed Link: 28611940
Variant Present in the following documents:
  • Main text
  • fonc-07-00109.pdf
View BVdb publication page